实体器官移植中COVID-19概述
本文综述实体器官移植(SOT)受者COVID-19的文献,检索PubMed、Web of Science和Google Scholar,限制2019年1月1日至2021年12月1日发表的文章。疫情初期移植量下降但多数中心已回升;调整后SOT受者COVID-19死亡率与普通人群相似;预防是关键,疫苗接种和非药物干预并重。
要点
- 疫情初期实体器官移植量下降,但多数中心移植量已回升。
- 调整后SOT受者COVID-19死亡率与普通人群相似,抗病毒和抗炎治疗使用增加。
- 预防是SOT受者关键,疫苗接种及戴口罩、手卫生、保持物理距离并重。
核心结论
- COVID-19大流行持续对SOT候选者和受者产生重要影响,预防感染是最重要措施,需关注疫苗接种方法并持续传达戴口罩、保持物理距离和手卫生的必要性。
研究设计与样本
- 综述,检索PubMed、Web of Science和Google Scholar,限制2019年1月1日至2021年12月1日发表的文章。
主要发现
- COVID-19大流行初期导致实体器官移植量下降,但多数中心移植量已回升。
- 若干报告提示供者来源SARS-CoV-2感染仅发生于肺移植受者,SARS-CoV-2 PCR阳性供者的其他器官可能可安全使用,但这些数据仅限于病例系列。
- COVID-19感染后终末期肺病的移植日益常见,已实施的移植结局可接受。
- 移植候选者急性COVID-19时,在可行情况下应推迟移植。
- 调整后,SOT受者COVID-19后死亡率与普通人群相似,抗病毒和抗炎治疗使用明显增加。
临床怎么用
- 移植候选者急性COVID-19时,在可行情况下应推迟移植。
- SOT受者及与其接触者的疫苗接种是预防的基石之一。
- 戴口罩、手卫生和保持物理距离等非药物干预同样始终重要。
局限性
- 供者来源SARS-CoV-2感染仅见于肺移植受者、其他器官可能可安全使用的数据仅限于病例系列。
- 供者选择仍是一个未完全明确的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic has influenced the field of solid organ transplantation (SOT) in many ways. COVID-19 has led to programmatic impacts and changes in donor and recipient selection. Several studies have evaluated the course, optimal treatment, and prevention of COVID-19 in SOT recipients. OBJECTIVES: To review the literature on COVID-19 in SOT recipients. SOURCES: PubMed, Web of Science, and Google Scholar were searched. The search was restricted to articles published between January 1, 2019 and December 1, 2021. CONTENT: The COVID-19 pandemic initially led to a decreased volume of solid organ transplants. However, transplant volumes at most centres have rebounded. Donor selection remains an incompletely defined issue. Several reports suggest that donor-derived SARS-CoV-2 infections occur only in lung transplant recipients and that other organs from SARS-CoV-2 PCR-positive donors could potentially be safely used. However, these data are limited to case series. Transplantation for end-stage lung disease after COVID-19 infection is increasingly common and has been performed with acceptable outcomes. In acute COVID-19 in a transplant candidate, transplantation should be delayed when feasible. After adjustment, mortality after COVID-19 appear similar in SOT recipients compared to the general population, with notable increased use of antiviral and anti-inflammatory treatment options. Prevention of COVID-19 is key in SOT recipients. Vaccination of SOT recipients and anyone who is in contact with SOT recipients is one of the cornerstones of prevention. Nonpharmacological interventions such as face coverings, hand hygiene, and physical distancing remain ever important as well. IMPLICATIONS: The COVID-19 pandemic continues to have an important impact on SOT candidates and recipients. Prevention of infection is the most important measure and requires careful attention to approaches to vaccination and messaging of the ongoing need for face coverings, physical distancing, and hand hygiene.
引用
- Bartelt L, van Duin D. An overview of COVID-19 in solid organ transplantation. Clin Microbiol Infect. 2022. PMID: 35189336. doi:10.1016/j.cmi.2022.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。